Centiva Capital’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.27M | Sell |
26,036
-2,151
| -8% | -$188K | 0.04% | 143 |
|
2025
Q1 | $1.92M | Buy |
28,187
+18,710
| +197% | +$1.28M | 0.06% | 117 |
|
2024
Q4 | $737K | Sell |
9,477
-13,650
| -59% | -$1.06M | 0.02% | 426 |
|
2024
Q3 | $1.55M | Buy |
23,127
+19,867
| +609% | +$1.33M | 0.03% | 306 |
|
2024
Q2 | $370K | Sell |
3,260
-845
| -21% | -$95.8K | 0.01% | 934 |
|
2024
Q1 | $569K | Buy |
+4,105
| New | +$569K | 0.01% | 641 |
|
2023
Q4 | – | Sell |
-16,830
| Closed | -$1.57M | – | 1353 |
|
2023
Q3 | $1.57M | Buy |
16,830
+677
| +4% | +$63.2K | 0.03% | 240 |
|
2023
Q2 | $2.08M | Buy |
+16,153
| New | +$2.08M | 0.05% | 202 |
|
2023
Q1 | – | Sell |
-17,104
| Closed | -$1.94M | – | 1160 |
|
2022
Q4 | $1.94M | Buy |
+17,104
| New | +$1.94M | 0.05% | 174 |
|
2022
Q2 | – | Sell |
-624
| Closed | -$80K | – | 1282 |
|
2022
Q1 | $80K | Sell |
624
-9,252
| -94% | -$1.19M | ﹤0.01% | 921 |
|
2021
Q4 | $1.33M | Buy |
+9,876
| New | +$1.33M | 0.03% | 254 |
|